ADAMTSL4 and central nervous system cancer: In the CGGA RNA-seq database, ADAMTSL4 was significantly higher expressed in GBM (WHO grade IV) compared to lower-grade gliomas (LGG, including grade II and grade III gliomas) (p < 0.001, Figure 1(b)).